These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8710790)

  • 1. [CD34 detection--an immunohistochemical contribution to differential diagnosis of soft tissue tumors].
    Katenkamp D; Mentzel T; Kosmehl H
    Pathologe; 1996 May; 17(3):195-201. PubMed ID: 8710790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of bcl-2 oncoprotein in benign and malignant spindle cell tumors of soft tissue, skin, serosal surfaces, and gastrointestinal tract.
    Suster S; Fisher C; Moran CA
    Am J Surg Pathol; 1998 Jul; 22(7):863-72. PubMed ID: 9669348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical characterization of dermatofibrosarcoma protuberans with practical applications for diagnosis and treatment.
    Haycox CL; Odland PB; Olbricht SM; Piepkorn M
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):438-44. PubMed ID: 9308560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B72.3 and CD34 immunoreactivity in malignant epithelioid soft tissue tumors. Adjuncts in the recognition of endothelial neoplasms.
    Sirgi KE; Wick MR; Swanson PE
    Am J Surg Pathol; 1993 Feb; 17(2):179-85. PubMed ID: 7678485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD34 and factor-XIIIa immunoreactivity in dermatofibrosarcoma protuberans and dermatofibroma.
    Goldblum JR; Tuthill RJ
    Am J Dermatopathol; 1997 Apr; 19(2):147-53. PubMed ID: 9129699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histogenetic relations between giant cell fibroblastoma and dermatofibrosarcoma protuberans. CD34 staining showing the spectrum and a simulator.
    Harvell JD; Kilpatrick SE; White WL
    Am J Dermatopathol; 1998 Aug; 20(4):339-45. PubMed ID: 9700370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apo D in soft tissue tumors: a novel marker for dermatofibrosarcoma protuberans.
    West RB; Harvell J; Linn SC; Liu CL; Prapong W; Hernandez-Boussard T; Montgomery K; Nielsen TO; Rubin BP; Patel R; Goldblum JR; Brown PO; van de Rijn M
    Am J Surg Pathol; 2004 Aug; 28(8):1063-9. PubMed ID: 15252314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurofibromatous changes in dermatofibrosarcoma protuberans: a potential pitfall in the diagnosis of a serious cutaneous soft tissue neoplasm.
    Kovarik CL; Hsu MY; Cockerell CJ
    J Cutan Pathol; 2004 Aug; 31(7):492-6. PubMed ID: 15239679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spindle cell lipoma is strongly CD34 positive. An immunohistochemical study.
    Templeton SF; Solomon AR
    J Cutan Pathol; 1996 Dec; 23(6):546-50. PubMed ID: 9001985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of CD34 and D2-40 in the Differentiation of Dermatofibroma and Dermatofibrosarcoma Protuberans.
    Sadullahoğlu C; Dere Y; Atasever TR; Öztop MT; Karaaslan Ö
    Turk Patoloji Derg; 2017; 1(1):223-227. PubMed ID: 28832078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Extrapleural solitary fibrous tumor with uncommon histology: a clinicopathologic analysis of 7 cases].
    Zhao M; Yang ZR; Wang YB; Chen Y; Qi GW; Yan YJ; Xu WJ; Ru GQ; He XL
    Zhonghua Bing Li Xue Za Zhi; 2018 Jan; 47(1):51-56. PubMed ID: 29325251
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical and pathological features of pediatric dermatofibrosarcoma protuberans.
    Keshen TH; Cederna PS; Savell VH; Platz CE; Chang P; Ricciardelli EJ
    Ann Plast Surg; 1995 Dec; 35(6):633-7. PubMed ID: 8748347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dermatofibrosarcoma protuberans treated with Mohs surgery. A case with CD34 immunostaining variability.
    Garcia C; Viehman G; Hitchcock M; Clark RE
    Dermatol Surg; 1996 Feb; 22(2):177-9. PubMed ID: 8608381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of HMGA1 and HMGA2 in dermatofibroma and dermatofibrosarcoma protuberans: potential diagnostic applications, and comparison with histologic findings, CD34, and factor XIIIa immunoreactivity.
    Li N; McNiff J; Hui P; Manfioletti G; Tallini G
    Am J Dermatopathol; 2004 Aug; 26(4):267-72. PubMed ID: 15249855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Giant fibrous hamartoma of infancy: pitfall of CD34 positive dermal mesenchymal tumor.
    Miroux-Catarino A; Claro C; Viana I
    Dermatol Online J; 2018 Jun; 24(6):. PubMed ID: 30142714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An update on selected cutaneous (myo) fibroblastic mesenchymal tumors.
    Georgantzoglou N; Linos K
    Semin Diagn Pathol; 2023 Jul; 40(4):295-305. PubMed ID: 37150655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD34 expression in desmoplastic melanoma.
    Hoang MP; Selim MA; Bentley RC; Burchette JL; Shea CR
    J Cutan Pathol; 2001 Nov; 28(10):508-12. PubMed ID: 11737519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dermatofibrosarcoma protuberans is a unique fibrohistiocytic tumour expressing CD34.
    Aiba S; Tabata N; Ishii H; Ootani H; Tagami H
    Br J Dermatol; 1992 Aug; 127(2):79-84. PubMed ID: 1382538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solitary fibrous tumors of the head and neck: a clinicopathologic and radiologic review.
    Ganly I; Patel SG; Stambuk HE; Coleman M; Ghossein R; Carlson D; Edgar M; Shah JP
    Arch Otolaryngol Head Neck Surg; 2006 May; 132(5):517-25. PubMed ID: 16702568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastrointestinal stromal tumors--value of CD34 antigen in their identification and separation from true leiomyomas and schwannomas.
    Miettinen M; Virolainen M; Maarit-Sarlomo-Rikala
    Am J Surg Pathol; 1995 Feb; 19(2):207-16. PubMed ID: 7530409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.